AYTU BIOPHARMA, INC Stock Issued During Period, Shares, Conversion of Convertible Securities
AYTU BIOPHARMA, INC (AYTU) reported Stock Issued During Period, Shares, Conversion of Convertible Securities of 600.00 thousand shares for the 9-month period ending 2014-05-31, per its 10-Q filed 2014-07-10.
Discontinued › Shareholders' Equity › Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2014-07-10
- 2014-05-31: Stock Issued During Period, Shares, Conversion of Convertible Securities 9 month 600.00K shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities 9 month |
|---|---|
| 2014-05-31 | 600.00K shares 10-Q · filed 2014-07-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |